Irregular vaginal bleeding with etonorgestrel contraceptive implant: a pilot randomised controlled trial of prophylactic down regulation with a gonadotrophin releasing hormone analogue [triptorelin] prior to implant insertion

Trial Profile

Irregular vaginal bleeding with etonorgestrel contraceptive implant: a pilot randomised controlled trial of prophylactic down regulation with a gonadotrophin releasing hormone analogue [triptorelin] prior to implant insertion

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 May 2016

At a glance

  • Drugs Triptorelin (Primary)
  • Indications Vaginal bleeding
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Dec 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials record.
    • 27 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top